SCHEMBL20141889

SCHEMBL20141889

CCCCC(CC(=O)O)N1CCC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 4/20 0.42
MAPK1 P28482 2/20 0.37
CA2 P00918 1/20 0.37
MAPT P10636 3/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
NPSR1 Q6W5P4 1/20 0.37
SLC6A2 P23975 1/20 0.36
SLC6A3 Q01959 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 1/20 0.35
ALDH1A1 P00352 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
FDPS P14324 1/20 0.34
FFAR4 Q5NUL3 1/20 0.33
AKR1B1 P15121 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PDF Q9HBH1 1/20 0.33
FFAR1 O14842 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11844785 0.96 GPR84 (0.42) GPR84MAPK1CA2MAPTL3MBTL1
SCHEMBL499960 0.85 POLB (0.40) GPR84MAPK1MAPTL3MBTL1NPSR1
SCHEMBL10885050 0.81 SLC6A3 (0.45) CA2SLC6A2SLC6A3MEN1KMT2A
SCHEMBL6212936 0.79 GPR84 (0.40) GPR84MAPK1CA2FFAR4FFAR1
SCHEMBL6214649 0.79 HTT (0.38) GPR84MAPK1CA2MAPTL3MBTL1
SCHEMBL10025245 0.77 SLC6A3 (0.49) MAPK1CA2MAPTL3MBTL1NPSR1
SCHEMBL25922001 0.77 HRH3 (0.37) MAPTSLC6A2SLC6A3ALDH1A1SIGMAR1
SCHEMBL25922002 0.77 HRH3 (0.37) MAPTSLC6A2SLC6A3ALDH1A1SIGMAR1
SCHEMBL500155 0.76 DPP7 (0.35) MAPK1SLC6A2SLC6A3TDP1
SCHEMBL10566713 0.76 SLC6A3 (0.48) MAPK1MAPTL3MBTL1NPSR1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538526-A1 CYCLOBUTANE- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS Bristol-Myers Squibb Company (US) 2019-09-18 EP disclosed
WO-2018089355-A1 CYCLOBUTANE- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed